Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has started its Phase 2 clinical trial of INM-755 (cannabinol) cream in the treatment of epidermolysis bullosa (“EB”). According to the company, this is the first time cannabinol has advanced to a Phase 2 clinical trial to be studied as a therapeutic option to treat a disease. The study will be conducted in seven different countries at 11 sites; the countries include Austria, Germany, Greece, France, Italy, Israel and Serbia. The company has filed clinical trial applications in all seven countries and has received approval from Austria, France, Greece and Israel, with the first site initiation visit being completed at a clinical site in Austria. Screening for eligible participants is set to begin in Austria soon. INM-755 is a cannabinol cream being considered as a topical therapy to treat EB and potentially other dermatological diseases. Currently EB has very few treatment options. “The achievement of this important milestone along the continuum of pharmaceutical drug development in EB supports our belief that this class of compounds hold broad therapeutic potential,” said InMed president and CEO Eric A. Adams in the press release. “This study further demonstrates InMed’s leadership in the development of rare cannabinoids as therapeutic products. In addition, we look forward to achieving key milestones of our second CBN drug candidate for the treatment of glaucoma in the year ahead.”

To view the full press releases, visit https://ibn.fm/ZlNjl

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”); the company is developing IntegraSyn(TM) to produce pharmaceutical-grade cannabinoids. INM is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based medicines. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Growing Numbers of Menopausal Women Resort to Cannabis for Symptomatic Relief

Between the ages of 45 to 55, most women will experience menopause as their estrogen levels steadily decline. One in 100 women will start going through this inevitable stage of life before they hit age 40. Regardless of when menopause starts, the symptoms associated with it are similar across the board. They include irregular periods, chills, hot flashes, night sweats, sleep problems, mood changes and weight gain among others.

Although some medications are proven to help women weather these symptoms, an increasing number of women have been turning to cannabis for this purpose. According to a new study, a “good number” of midlife women have been using the controversial plant, believing that it will help to treat some of the more uncomfortable menopause symptoms. Katherine Babyn, lead researcher and a graduate student at the University of Alberta in Canada, says that plenty of middle-aged women in the menopause transition period of their lives are using cannabis to alleviate symptoms that “tend to overlap with menopause.”

But can cannabis actually help women deal with these symptoms? Dr. Stephanie Faubion, medical director of the North American Menopause Society (“NAMS”), says that unfortunately, there is minimal scientific evidence proving that cannabis can effectively treat menopause-related symptoms. Since marijuana’s effect on women going through menopause hasn’t been formally studied, she says, we do not know the possible benefits and risks. Consequently, women who are using cannabis to alleviate their symptoms are essentially using a drug that has not been studied.

However, the study revealed that plenty of middle-aged women feel like they have benefited from using cannabis. The researchers from the University of Alberta surveyed an estimated 1,500 middle-aged women from the province of Alberta in Canada and found that two-thirds of the respondents had used cannabis for some time, with one-third having done so within the past month. Of the women who were currently using cannabis, 75% said they were using it for medical purposes. This is despite the fact that only 23% actually had medical marijuana prescriptions.

In addition, the study reported that 52% consumed edibles, 47% used cannabis oils, 41% preferred to smoke, and 26% vaped. Up to 74% of the respondents said their symptoms had improved once they started using cannabis, says Nese Yuksel, senior researcher and a professor of pharmacy and pharmaceutical sciences at the University of Alberta. Other noteworthy stats include 74% of respondents reported using cannabis to sleep better, 59% used it for anxiety, 58% to boost concentration, 55% to reduce feelings of irritability, and 53% to alleviate muscle and joint aches.

Still, Yuksel says that without any scientific backing, the researchers cannot make an association between cannabis use and reduced menopause symptoms. Although the women may feel as if they’re seeing some benefit from consuming cannabis, she says, the researchers cannot conclusively say that the drug can treat menopause symptoms. Ultimately, they all agreed that we need more research on marijuana’s potential benefits and risks to see whether or not it can be an effective treatment for menopause symptoms.

Companies that manufacture a variety of CBD products, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), may inadvertently be helping menopausal women if some of the preliminary studies on cannabidiol, a major compound in cannabis, are anything to go by.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Amazon Voices Support for Federal Cannabis Legalization, Ends Employee Drug Testing

Amazon recently let up on its screening policies for cannabis, with company officials vocalizing their support for the federal legalization of the plant. Beth Galetti, who is the company’s HR boss, stated that the company had restored employment eligibility for applicants and past employees who had been denied employment or fired during cannabis screenings.

Galetti added that pre-employment cannabis testing had disproportionately impacted communities of color by impeding job placement and, by extension, the growth of the economy. She noted that this inequitable treatment was unacceptable.

Earlier in June, company officials stated that they would no longer screen their workers for cannabis. This is excluding job candidates who are applying for positions that involve the operation of heavy equipment or truck drivers, as those positions are regulated by the federal Department of Transportation.

Amazon also revealed that following an incident, it would continue to conduct tests for alcohol and drugs and impairment checks on the job.

The international e-commerce company decided to let up on its cannabis standards after a growing number of states in the U.S. began legalizing the plant. Galetti notes that the loosened standards are expected to bring more job applicants into the company.

Thus far, marijuana has been legalized for recreational use in 18 states as well as in Guam, the Northern Mariana Islands and the District of Columbia. Medical marijuana is also legal in 36 states across the United States, as well as in the Virgin Islands, Puerto Rico, Guam and the District of Columbia.

In addition to this, Galleti stated that the company’s pace of growth meant that it was always in search of new members to add to its team. Recently Amazon has been using various incentives, including free college tuition and hiring bonuses, in an attempt to attract more applicants. Now company officials have announced plans to removing pre-employment testing for marijuana, which would allow the company to extend its applicant pool.

The trillion-dollar company is also calling for the federal government to legalize cannabis, with company officials revealing that they support the Marijuana Opportunity Reinvestment and Expungement (“MORE”) Act. The objective of the act is to invest in communities that have been affected by the drug war, expunge criminal records for those incarcerated for possession and decriminalize marijuana at the federal level.

Recently, Amazon threw its weight behind similar legislation dubbed the Cannabis Administration and Opportunity Act. In a letter addressed to legislators about this measure, the renowned company urged Congress to allow for resentencing of any individuals serving time in federal prison for nonviolent cannabis crimes and expungement of the records for those crimes.

The increasing use of cannabis as a medicinal substance is causing a spike in the demand for IoT dose-measuring devices such as the ones made by RYAH Group Inc. (CSE: RYAH) alongside other enabling technologies.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) TRACE Product Line Named as Official Water Supplier of Canadian E-Fest

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event. This includes the highly anticipated Formula E electric car race, part of the ABB FIA Formula E World Championship series. The three-day Canadian E-Fest will welcome the ABB FIA Formula E World Championship and also offer plenty of action off-track beginning with a creative business conference on sustainability. Taking place on June 30 – July 2, 2022, the festival will feature a fan village, concerts by two top Canadian musical artists and the Formula E electric car race, the pinnacle of the event, to be held on July 2 in Vancouver’s False Creek. “BevCanna and TRACE are a perfect fit for Canadian E-Fest/Vancouver E-Prix’s commitment to sustainability,” said Matthew Carter, president and CEO, OSS Group. “As a local B.C. water company, bottling high-quality natural waters sourced from a B.C. aquifer, in fully recyclable containers, TRACE was a natural choice to be our water supplier.”

To view the full press release, visit https://cnw.fm/C5Ts1

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – USA CBD Expo to Shine the Spotlight on Industry’s Leading Professionals, Latest Trends

The next USA CDB Expo will be hosted at Chicago’s McCormick Place on Oct. 28-30, 2021. Following June’s Atlanta-based conference and its successful return to an in-person format, the nation’s largest CBD event series will continue with a three-day event in the Midwest that provides industry enthusiasts the opportunity to glean insight from more than 50 expert speakers, visit with hundreds of vendors and network with thousands of their peers. Presenting sponsor 3Chi, the nation’s largest CBN and Delta-8 distributor, is headlining October’s USA CBD Expo. The event represents an early celebration of the state’s second anniversary of the legalization of recreational consumption, possession and sale of cannabis products in Illinois. Within a short timeframe, Illinois’ recreational cannabis sector has grown to an estimated $40 million per month in retail revenues, a clear testament to the industry’s positive potential and growth trajectory. Designed to cater to industry newcomers and experts alike, the conference will feature some of the CBD and hemp industry’s leading professionals presenting a series of educational seminars, keynote addresses and workshops. Seminars will cover a range of topics, including a focus on the commercial side of the CBD and hemp industry, current and future market trends, health benefits, ongoing legalization efforts, as well as medicinal use cases. In addition, some of the scheduled talks include CBD for sexual wellness, the power of medicinal mushroom extracts, psychedelics education, information about delta-8 and its legality, and other diverse topics.

To view the full press release, visit https://cnw.fm/4dkZ1

About USA CBD Expo

USA CBD Expo strives to create the best and largest CBD/hemp event in the nation, to consistently bring the most innovative and best products/brands to businesses and consumers, to compress a rapidly expanding industry into one all-encompassing, premier event. The team is committed to representing unrivaled passion through its events and is dedicated to presenting the benefits of CBD, a product it truly believes in. Buyers, businesses and consumers will find everything they need at USA CBD Expo shows. With 300+ vendors, the right product, the right brand and the right deal will be available all at once, only at the nation’s largest CBD event. For more information, visit www.USACBDExpo.com.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Provides Improved Delivery for Wide Range of Product Formats

Lexaria Bioscience Corp. (NASDAQ: LEXX), an innovator of drug delivery methods, is improving the speed and efficiency of orally delivered fat-soluble active molecules and drugs with its patented technology. “DehydraTECH promotes a more effective, less expensive form of oral drug delivery evaluated thoroughly in vivo, in vitro and human clinical testing,” reads a recent article. “The DehydraTECH technology is suitable for use with a wide range of product formats. These include pharmaceuticals, nutraceuticals, consumer packaged goods, and over-the-counter (‘OTC’) capsules, pills, tablets, and oral suspensions. The technology was specifically designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients into a more easily absorbable format, allowing them to enter the bloodstream more quickly and effectively.”

To view the full article, visit https://cnw.fm/rwuxL

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp.’s patented drug delivery technology, DehydraTECH(TM) improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted in nations with a combined population of 2.6 billion, and over 50 additional patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – The Alkaline Water Company Inc.’s (NASDAQ: WTER) (CSE: WTER) Alkaline88(R) Now Ranks as Country’s 8th Largest Enhanced Water

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today shared highlights from the most recent Nielsen data for the 52-week and four-week periods ending Sept. 11, 2021. According to the four-week data, Alkaline88(R) is now the 8th largest enhanced water in the country in the all-important grocery channel. The company’s unit growth in grocery outpaces the entire category by 12.6 times over the last year and 32 times over the past four weeks. “The Alkaline Water Company continues to grow and gain market share in the value-added water category,” said WTER president and CEO Ricky Wright. “According to Nielsen total U.S. food data for the 52-week period ended Sept. 11, 2021, we’re outpacing the category growth by 2.8x in dollar volume and 12.6x in unit volume. Over the past four-week period, the company has improved its position even further, becoming the eighth largest company in the category after surpassing LifeWTR, a PepsiCo brand. We are outpacing the category by 23.8% in dollar volume and 31% in unit volume. Over the past four weeks, growth has accelerated, and we are back within our 35-50% target growth range. Our overall dollar volume growth is 39.4% compared to this same period a year ago and we’ve also picked up .6% in market share, outperforming all but one of the other top-ten brands.”

To view the full press release, visit https://cnw.fm/Jfw44

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for the Alkaline88 and A88 Infused brands. To purchase Alkaline88 and A88 Flavor Infused products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Enters Strategic Partnership, Consulting Contract with Lelantos Holdings Inc.

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, today announced that it has executed a partnership and consulting contract with Lelantos Holdings Inc. The collaboration is intended to assist the company in becoming publicly traded while also providing business advisory services for an array of strategic projects. Lelantos Holdings, a corporate advisory company that seeks to acquire, purchase and/or joint venture with established entities in strategic and emerging market sectors, is managed and operated by the founders of Sonder Fulfillment LLC, a wholly owned subsidiary of Golden Triangle Ventures. “We have invested over $500,000 into Lelantos Holdings over the past year, which has helped capitalize the development of a large agricultural refining operation in Michigan. This is a flagship project within Lelantos Holdings that will represent one of the many company operations in the United States and abroad,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “With their developing international business, along with deep roots and relationships tied into the states, this gives our company great confidence that Lelantos Holdings will become not only an amazing partner and client of ours but also a leading force in the industries it does business in. We greatly look forward to disclosing lots of exciting information about everything within Lelantos Holdings and how this relationship benefits all of our shareholders on the road ahead.”

To view the full press release, visit https://cnw.fm/RPHWX

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Benefits of Switching to Hemp Fashion, Clothing

As the popularity of cannabis grows, so does that of the hemp plant. Hemp is a variety of the cannabis sativa plant, which has various industrial applications, including as a construction material. Hemp is a highly sustainable crop that can nourish the soil without the need of pesticides. The plant’s stalk has low levels of THC and is fibrous. Its fabric, which is not only durable, long lasting and efficient, is soft and comfortable on the skin.

You can find bedding items such as blankets, duvets and bedsheets, as well as tablecloths and clothes, including skirts, pants, jackets and dresses made from hemp. Below are some benefits of hemp fabric.

Softens with time

As mentioned above, clothes made from hemp are comfortable to wear and, with every wash, they get softer. The clothes also don’t get distorted after multiple washes and uses.

Features antimicrobial properties

Unlike other fabrics such as polyester and cotton, hemp fabric fights against bacteria such as those that cause body odor. Hemp fabric is also resistant to mildew and mold.

Wears well

In addition to being easy on the skin, the fabric is breathable and easily absorbs sweat. Hemp fabric is also resistant to fading and is easy to dye.

Good for soil health

Hemp can be grown in almost any soil and it helps restore some of the important nutrients that may have been lost in that soil. Hemp cultivators can plant hemp as part of crop rotation as well as grow multiple cycles of the plant on the same parcel of land. The plant is also pest resistant, and it doesn’t require fertilizers because its leaves provide enough to the soil when they shed. In addition, hemp is biodegradable

Doesn’t require large amounts of water

Hemp can thrive even without a lot of water, unlike other plants such as cotton, which need lots hydration. The infrequent use of chemicals for hemp cultivation also helps avoid soil erosion, which in turn spares water bodies from pollution.

Good for the environment

Almost every industry globally has a carbon footprint, including the fashion industry, which is a huge contributor to environmental and global-warming issues. Adopting hemp clothing to replace fast fashion will help absorb more carbon dioxide from the atmosphere as well as combat other climate issues.

As seen above, hemp is the crop that can almost do it all. Given its applications not only in the fashion industry but other industries as well, it makes sense to use hemp, both for a better environment and a better world.

The increasing awareness of the ecobenefits of hemp clothing has resulted in the hemp clothing made by companies such as Flora Growth Corp. (NASDAQ: FLGC) to skyrocket in popularity among consumers who are concerned about the carbon footprint of the fabrics they wear.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Is CBD Addictive?

If you still haven’t used a cannabidiol (“CBD”) product, I bet you know someone who has. CBD became legal more than two years ago when the 2018 Farm Bill legalized the cultivation and sale of industrial hemp and its derivatives. It is one of more than 100 chemical compounds called cannabinoids that are produced by plants in the cannabis family. But unlike marijuana, hemp has minimal amounts of THC (delta-9 tetrahydrocannabinol), the main chemical agent that makes marijuana intoxicating.

As such, CBD is nonpsychoactive, meaning it will not intoxicate you. However, the hemp extract has become incredibly popular within quite a short period for a reason; it is claimed to be full of potent medical properties. People from all over the country have since been using CBD to treat chronic pain, alleviate anxiety and depression, and treat skin conditions such as acne and psoriasis. Furthermore, the U.S. Food and Drug Administration (“FDA”) has approved the use of a CBD formulation called Epidiolex to treat Dravet Syndrome and Lennox-Gastaut Syndrome, two rare types of pediatric epilepsy that are extremely hard to treat.

But as CBD becomes more accessible to the public and more people turn to the cannabinoid to address several health issues, one question has echoed in the minds of the public and experts alike: is CBD addictive? With a whopping 33% of Americans claiming to have used CBD at least once in the past, how likely are regular CBD users to get addicted?

According to the limited resources available, it looks like CBD may not be addictive partly due to the fact that it does not have intoxicating effects. A small 2016 study found that, unlike THC, CBD does not produce significant physical and psychological effects such as euphoria and rapid heart rate. When the study participants reported about feelings of intoxication, CBD performed similarly to a placebo.

In fact, studies have found that cannabidiol works contrary to addiction, helping individuals with drug addiction to kick their drug habits. Preliminary studies have found that rather than being an addictive substance, such as alcohol or nicotine, CBD may be able to actually reduce the likelihood of developing a methamphetamine or cocaine-use disorder.

A 2015 systematic review of available preclinical and clinical data covering the effect of cannabidiol on addictive behaviors concluded that there’s a good chance that CBD may be able to help in the treatment of tobacco and alcohol addiction. Although there is limited research on both the benefits and risks of CBD, the cannabinoid does not appear to be addictive. However, further research is needed to be completely sure of its potential for addiction as well as its potential for treating other drug use disorders.

It is gratifying to know that the CBD products made by companies such as Golden Triangle Ventures Inc. (OTC: GTVH) could potentially play a part in enhancing the health of the consumers of those products, if preliminary research is anything to go by.

NOTE TO INVESTORS: The latest news and updates relating to Golden Triangle Ventures Inc. (OTC: GTVH) are available in the company’s newsroom at https://cnw.fm/GTVH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.